A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target
The identification of new drug targets is highly challenging, particularly for diseases of the brain. This study describes a general computational gene regulatory framework called CRAFT for drug target discovery, and the authors use CRAFT to identify the microglial membrane receptor Csf1R as a poten...
Guardado en:
Autores principales: | Prashant K. Srivastava, Jonathan van Eyll, Patrice Godard, Manuela Mazzuferi, Andree Delahaye-Duriez, Juliette Van Steenwinckel, Pierre Gressens, Benedicte Danis, Catherine Vandenplas, Patrik Foerch, Karine Leclercq, Georges Mairet-Coello, Alvaro Cardenas, Frederic Vanclef, Liisi Laaniste, Isabelle Niespodziany, James Keaney, Julien Gasser, Gaelle Gillet, Kirill Shkura, Seon-Ah Chong, Jacques Behmoaras, Irena Kadiu, Enrico Petretto, Rafal M. Kaminski, Michael R. Johnson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c0cffc3635504945bbe2f39f8175da2f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
High prevalence of drug resistance in animal trypanosomes without a history of drug exposure.
por: Simbarashe Chitanga, et al.
Publicado: (2011) -
Network neighbors of drug targets contribute to drug side-effect similarity.
por: Lucas Brouwers, et al.
Publicado: (2011) -
Drugs
Publicado: (1971) -
DrugEx v2: de novo design of drug molecules by Pareto-based multi-objective reinforcement learning in polypharmacology
por: Xuhan Liu, et al.
Publicado: (2021) -
A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities
por: Ravi S. Narayan, et al.
Publicado: (2020)